JMP Securities initiates coverage of CLSD with "outperform." Stock up 7%.
Analysts at JMP Securities initiated coverage on Clearside Biomedical Inc CLSD with a Market Outperform rating. The price target for Clearside Biomedical is set to $21. Clearside Biomedical shares closed at $7.54 on Wednesday.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.